Pharmacies To Distribute MedWatch Number Under FDA Adverse Event Reporting Rule
This article was originally published in The Pink Sheet Daily
Executive Summary
The proposal incorporates Best Pharmaceuticals for Children Act provisions into the existing MedWatch program. The compliance costs for pharmacies already providing written consumer medication information is expected to be low.